Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-19 | Avidity Biosciences, Inc. | LEVIN ARTHUR A
(Director) |
S | Common Stock | D | 5000 | $22.82 - $22.82 | $114,123 |
| 2024-04-19 | Avidity Biosciences, Inc. | LEVIN ARTHUR A
(Director) |
M | Common Stock | A | 5000 | $1.24 - $1.24 | $6,200 |
| 2024-04-03 | Avidity Biosciences, Inc. | LEVIN ARTHUR A
(Director) |
S | Common Stock | D | 20000 | $27.11 - $27.11 | $542,214 |
| 2024-04-02 | Avidity Biosciences, Inc. | Boyce Sarah
(President and CEO) |
S | Common Stock | D | 28000 | $26.25 - $26.25 | $734,918 |
| 2024-04-02 | Avidity Biosciences, Inc. | Boyce Sarah
(President and CEO) |
M | Common Stock | A | 28000 | $1.24 - $1.24 | $34,720 |
| 2024-03-12 | Avidity Biosciences, Inc. | LEVIN ARTHUR A
(Director) |
S | Common Stock | D | 27641 | $22.00 - $22.04 | $609,017 |
| 2024-03-12 | Avidity Biosciences, Inc. | LEVIN ARTHUR A
(Director) |
M | Common Stock | A | 25000 | $1.24 - $1.24 | $31,000 |
| 2024-01-22 | Avidity Biosciences, Inc. | LEVIN ARTHUR A
(Director) |
S | Common Stock | D | 1859 | $10.13 - $10.13 | $18,831 |
| 2024-01-22 | Avidity Biosciences, Inc. | Boyce Sarah
(President and CEO) |
S | Common Stock | D | 5092 | $10.13 - $10.13 | $51,581 |
| 2024-01-20 | Avidity Biosciences, Inc. | Boyce Sarah
(President and CEO) |
A | Common Stock | A | 62500 | $0.00 - $0.00 | $0 |
| 2024-01-22 | Avidity Biosciences, Inc. | Flanagan W. Michael
(CSTO) |
S | Common Stock | D | 4129 | $10.13 - $10.13 | $41,826 |
| 2024-01-20 | Avidity Biosciences, Inc. | Flanagan W. Michael
(CSTO) |
A | Common Stock | A | 20000 | $0.00 - $0.00 | $0 |
| 2024-01-22 | Avidity Biosciences, Inc. | McCarthy Teresa
(Chief Human Resources Officer) |
S | Common Stock | D | 2065 | $10.13 - $10.13 | $20,918 |
| 2024-01-20 | Avidity Biosciences, Inc. | McCarthy Teresa
(Chief Human Resources Officer) |
A | Common Stock | A | 16500 | $0.00 - $0.00 | $0 |
| 2024-01-22 | Avidity Biosciences, Inc. | MacLean Michael F
(Chief Financial Officer) |
S | Common Stock | D | 1616 | $10.13 - $10.13 | $16,370 |
| 2024-01-20 | Avidity Biosciences, Inc. | MacLean Michael F
(Chief Financial Officer) |
A | Common Stock | A | 22500 | $0.00 - $0.00 | $0 |
| 2023-12-12 | Avidity Biosciences, Inc. | WILSON TROY EDWARD
(Director) |
J | Common Stock | D | 1100000 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |